Related Experiment Videos

[Absence of nocturnal decrease in blood pressure in 24-hour blood pressure monitoring: an indication of secondary

I Schrader1, C Person, U Pfertner

  • 1Abteilung für Nephrologie und Rheumatologie, Medizinische Universitätsklinik Göttingen.

Klinische Wochenschrift
|July 3, 1989
PubMed

Insights

The absence of a normal nighttime blood pressure drop during 24-hour ambulatory monitoring may indicate secondary hypertension. This finding helps differentiate secondary hypertension from essential hypertension, aiding diagnosis.

Area of Science:

  • Nephrology
  • Cardiology
  • Endocrinology

Context:

  • Secondary hypertension affects a significant patient population.
  • Differentiating secondary from essential hypertension is crucial for effective treatment.
  • Ambulatory blood pressure monitoring (ABPM) provides insights into circadian blood pressure patterns.

Purpose:

  • To investigate the diagnostic value of circadian blood pressure patterns in identifying secondary hypertension.
  • To compare 24-hour ambulatory blood pressure monitoring (ABPM) results between patients with secondary hypertension and essential hypertension.
  • To assess the impact of treating underlying conditions on blood pressure circadian rhythms.

Summary:

  • A study compared 81 patients with secondary hypertension (various causes) to 201 with essential hypertension using 24-hour ABPM.
  • Essential hypertension typically shows a nightly blood pressure decline (≥15 mmHg), observed in 98.5% of patients.
  • 69% of secondary hypertension patients exhibited an attenuated or absent nocturnal blood pressure dip, with pheochromocytoma, diabetic nephropathy, Conn's disease, and post-transplant patients showing the most significant deviations.

Impact:

  • The absence of a nocturnal blood pressure decline during ABPM is a potential indicator of secondary hypertension.
  • Restoration of circadian blood pressure rhythm post-treatment suggests the reversibility of hypertensive mechanisms.
  • These findings can improve the diagnostic pathway for secondary hypertension, leading to more targeted therapies.

Related Concept Videos